These results suggest that AXIN1 is a regulator of sensitivity to TRAIL-induced apoptosis in melanoma, and that decreasing AXIN1 levels can confer sensitivity to apoptosis with TRAIL in previously insensitive cell lines. This evidence concerns the gene TNFSF10 and melanoma.